Alteration of Panel-Reactive Antibodies Following Treatment With Either Atorvastatin or Low-Dose Mycophenolate Mofetil in Sensitized Hemodialysis Patients.
Iranian Journal of Kidney Diseases,
[S. l.], v. 5, n. 5, p. 342–346, 2011. Disponível em:
https://ijkd.org/index.php/ijkd/article/view/364. Acesso em: 5 jul. 2025.